APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ioversol Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ioversol Injection Market Analysis and Forecast 2026-2032

Report ID 174004490229 December 2025196 pages

Choose your research edition.

Industry ResearchIoversol Injection Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Ioversol Injection Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Ioversol Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ioversol Injection Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ioversol Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Ioversol Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Ioversol Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ioversol Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ioversol Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ioversol Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Ioversol Injection include GUERBET, Zhejiang Starry Pharmaceutical, Hengrui Pharmaceuticals, Bayer HealthCare Pharmaceuticals, Neptunus Bio-pharmaceutical, Liebel-Flarsheim Company LLC and Bracco Imaging S.p.A., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Ioversol Injection, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ioversol Injection, also provides the revenue of main regions and countries. Of the upcoming market potential for Ioversol Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ioversol Injection revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ioversol Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Ioversol Injection revenue, projected growth trends, production technology, application and end-user industry.

Ioversol Injection Segment by Company

GUERBET

Zhejiang Starry Pharmaceutical

Hengrui Pharmaceuticals

Bayer HealthCare Pharmaceuticals

Neptunus Bio-pharmaceutical

Liebel-Flarsheim Company LLC

Bracco Imaging S.p.A.

Ioversol Injection Segment by Type

50mL

75mL

100mL

125mL

Ioversol Injection Segment by Application

Hospital

Clinic

Others

Ioversol Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ioversol Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ioversol Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ioversol Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Ioversol Injection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Ioversol Injection company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ioversol Injection revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ioversol Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 50mL Major Player Table 3. 75mL Major Player Table 4. 100mL Major Player Table 5. 125mL Major Player Table 6. Global Ioversol Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Clinic Major Player Table 9. Others Major Player Table 10. Ioversol Injection Industry Trends Table 11. Ioversol Injection Industry Drivers Table 12. Ioversol Injection Industry Opportunities and Challenges Table 13. Ioversol Injection Industry Restraints Table 14. Global Ioversol Injection Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Ioversol Injection Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Ioversol Injection Market Share by Region (2021-2026) Table 17. Global Ioversol Injection Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Ioversol Injection Market Share by Region (2027-2032) Table 19. Global Ioversol Injection Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Ioversol Injection Revenue Market Share by Players (2021-2026) Table 21. Global Ioversol Injection Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Ioversol Injection Key Players Headquarters & Area Served Table 23. Global Ioversol Injection Players, Product Type & Application Table 24. Global Ioversol Injection Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Ioversol Injection by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Ioversol Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Ioversol Injection Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Ioversol Injection Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Ioversol Injection Revenue Market Share by Type (2021-2026) Table 31. Global Ioversol Injection Revenue Market Share by Type (2027-2032) Table 32. Global Ioversol Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Ioversol Injection Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Ioversol Injection Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Ioversol Injection Revenue Market Share by Application (2021-2026) Table 36. Global Ioversol Injection Revenue Market Share by Application (2027-2032) Table 37. GUERBET Company Information Table 38. GUERBET Business Overview Table 39. GUERBET Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. GUERBET Ioversol Injection Product Portfolio Table 41. GUERBET Recent Development Table 42. Zhejiang Starry Pharmaceutical Company Information Table 43. Zhejiang Starry Pharmaceutical Business Overview Table 44. Zhejiang Starry Pharmaceutical Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Zhejiang Starry Pharmaceutical Ioversol Injection Product Portfolio Table 46. Zhejiang Starry Pharmaceutical Recent Development Table 47. Hengrui Pharmaceuticals Company Information Table 48. Hengrui Pharmaceuticals Business Overview Table 49. Hengrui Pharmaceuticals Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Hengrui Pharmaceuticals Ioversol Injection Product Portfolio Table 51. Hengrui Pharmaceuticals Recent Development Table 52. Bayer HealthCare Pharmaceuticals Company Information Table 53. Bayer HealthCare Pharmaceuticals Business Overview Table 54. Bayer HealthCare Pharmaceuticals Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Bayer HealthCare Pharmaceuticals Ioversol Injection Product Portfolio Table 56. Bayer HealthCare Pharmaceuticals Recent Development Table 57. Neptunus Bio-pharmaceutical Company Information Table 58. Neptunus Bio-pharmaceutical Business Overview Table 59. Neptunus Bio-pharmaceutical Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Neptunus Bio-pharmaceutical Ioversol Injection Product Portfolio Table 61. Neptunus Bio-pharmaceutical Recent Development Table 62. Liebel-Flarsheim Company LLC Company Information Table 63. Liebel-Flarsheim Company LLC Business Overview Table 64. Liebel-Flarsheim Company LLC Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Liebel-Flarsheim Company LLC Ioversol Injection Product Portfolio Table 66. Liebel-Flarsheim Company LLC Recent Development Table 67. Bracco Imaging S.p.A. Company Information Table 68. Bracco Imaging S.p.A. Business Overview Table 69. Bracco Imaging S.p.A. Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Bracco Imaging S.p.A. Ioversol Injection Product Portfolio Table 71. Bracco Imaging S.p.A. Recent Development Table 72. North America Ioversol Injection Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Ioversol Injection Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Ioversol Injection Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Ioversol Injection Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Ioversol Injection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. North America Ioversol Injection Revenue by Country (2021-2026) & (US$ Million) Table 78. North America Ioversol Injection Revenue by Country (US$ Million) & (2027-2032) Table 79. Europe Ioversol Injection Revenue by Type (2021-2026) & (US$ Million) Table 80. Europe Ioversol Injection Revenue by Type (2027-2032) & (US$ Million) Table 81. Europe Ioversol Injection Revenue by Application (2021-2026) & (US$ Million) Table 82. Europe Ioversol Injection Revenue by Application (2027-2032) & (US$ Million) Table 83. Europe Ioversol Injection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. Europe Ioversol Injection Revenue by Country (2021-2026) & (US$ Million) Table 85. Europe Ioversol Injection Revenue by Country (US$ Million) & (2027-2032) Table 86. China Ioversol Injection Revenue by Type (2021-2026) & (US$ Million) Table 87. China Ioversol Injection Revenue by Type (2027-2032) & (US$ Million) Table 88. China Ioversol Injection Revenue by Application (2021-2026) & (US$ Million) Table 89. China Ioversol Injection Revenue by Application (2027-2032) & (US$ Million) Table 90. Asia Ioversol Injection Revenue by Type (2021-2026) & (US$ Million) Table 91. Asia Ioversol Injection Revenue by Type (2027-2032) & (US$ Million) Table 92. Asia Ioversol Injection Revenue by Application (2021-2026) & (US$ Million) Table 93. Asia Ioversol Injection Revenue by Application (2027-2032) & (US$ Million) Table 94. Asia Ioversol Injection Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 95. Asia Ioversol Injection Revenue by Region (US$ Million) & (2021-2026) Table 96. Asia Ioversol Injection Revenue by Region (US$ Million) & (2027-2032) Table 97. SAMEA Ioversol Injection Revenue by Type (2021-2026) & (US$ Million) Table 98. SAMEA Ioversol Injection Revenue by Type (2027-2032) & (US$ Million) Table 99. SAMEA Ioversol Injection Revenue by Application (2021-2026) & (US$ Million) Table 100. SAMEA Ioversol Injection Revenue by Application (2027-2032) & (US$ Million) Table 101. SAMEA Ioversol Injection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. SAMEA Ioversol Injection Revenue by Country (2021-2026) & (US$ Million) Table 103. SAMEA Ioversol Injection Revenue by Country (US$ Million) & (2027-2032) Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Ioversol Injection Image Figure 2. Global Ioversol Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ioversol Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 50mL Image Figure 5. 75mL Image Figure 6. 100mL Image Figure 7. 125mL Image Figure 8. Global Ioversol Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Ioversol Injection Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Ioversol Injection Market Size (US$ Million) & (2021-2032) Figure 14. Global Ioversol Injection Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Ioversol Injection Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Ioversol Injection Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Ioversol Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Ioversol Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Ioversol Injection Revenue Market Share by Type (2021-2032) Figure 21. Global Ioversol Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Ioversol Injection Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Ioversol Injection Revenue Market Share by Application (2021-2032) Figure 24. North America Ioversol Injection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Ioversol Injection Revenue Share by Type (2021-2032) Figure 26. North America Ioversol Injection Revenue Share by Application (2021-2032) Figure 27. North America Ioversol Injection Revenue Share by Country (2021-2032) Figure 28. United States Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Ioversol Injection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Ioversol Injection Revenue Share by Type (2021-2032) Figure 33. Europe Ioversol Injection Revenue Share by Application (2021-2032) Figure 34. Europe Ioversol Injection Revenue Share by Country (2021-2032) Figure 35. Germany Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Ioversol Injection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Ioversol Injection Revenue Share by Type (2021-2032) Figure 45. China Ioversol Injection Revenue Share by Application (2021-2032) Figure 46. Asia Ioversol Injection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Ioversol Injection Revenue Share by Type (2021-2032) Figure 48. Asia Ioversol Injection Revenue Share by Application (2021-2032) Figure 49. Asia Ioversol Injection Revenue Share by Region (2021-2032) Figure 50. Japan Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Ioversol Injection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Ioversol Injection Revenue Share by Type (2021-2032) Figure 58. SAMEA Ioversol Injection Revenue Share by Application (2021-2032) Figure 59. SAMEA Ioversol Injection Revenue Share by Country (2021-2032) Figure 60. Brazil Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Ioversol Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 50mL
  • 75mL
  • 100mL
  • 125mL
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • GUERBET
  • Zhejiang Starry Pharmaceutical
  • Hengrui Pharmaceuticals
  • Bayer HealthCare Pharmaceuticals
  • Neptunus Bio-pharmaceutical
  • Liebel-Flarsheim Company LLC
  • Bracco Imaging S.p.A.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ioversol Injection Market by Type
  3. 1.2.1 Global Ioversol Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 50mL
  5. 1.2.3 75mL
  6. 1.2.4 100mL
  7. 1.2.5 125mL
  8. 1.3 Ioversol Injection Market by Application
  9. 1.3.1 Global Ioversol Injection Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Ioversol Injection Market Dynamics
  1. 2.1 Ioversol Injection Industry Trends
  2. 2.2 Ioversol Injection Industry Drivers
  3. 2.3 Ioversol Injection Industry Opportunities and Challenges
  4. 2.4 Ioversol Injection Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Ioversol Injection Market Perspective (2021-2032)
  2. 3.2 Global Ioversol Injection Growth Trends by Region
  3. 3.2.1 Global Ioversol Injection Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ioversol Injection Market Size by Region (2021-2026)
  5. 3.2.3 Global Ioversol Injection Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Ioversol Injection Revenue by Players
  2. 4.1.1 Global Ioversol Injection Revenue by Players (2021-2026)
  3. 4.1.2 Global Ioversol Injection Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Ioversol Injection Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ioversol Injection Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Ioversol Injection Key Players Headquarters & Area Served
  7. 4.4 Global Ioversol Injection Players, Product Type & Application
  8. 4.5 Global Ioversol Injection Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Ioversol Injection Market CR5 and HHI
  11. 4.6.3 2025 Ioversol Injection Tier 1, Tier 2, and Tier 3
5 Ioversol Injection Market Size by Type
  1. 5.1 Global Ioversol Injection Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Ioversol Injection Revenue by Type (2021-2032)
  3. 5.3 Global Ioversol Injection Revenue Market Share by Type (2021-2032)
6 Ioversol Injection Market Size by Application
  1. 6.1 Global Ioversol Injection Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Ioversol Injection Revenue by Application (2021-2032)
  3. 6.3 Global Ioversol Injection Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 GUERBET
  2. 7.1.1 GUERBET Company Information
  3. 7.1.2 GUERBET Business Overview
  4. 7.1.3 GUERBET Ioversol Injection Revenue and Gross Margin (2021-2026)
  5. 7.1.4 GUERBET Ioversol Injection Product Portfolio
  6. 7.1.5 GUERBET Recent Developments
  7. 7.2 Zhejiang Starry Pharmaceutical
  8. 7.2.1 Zhejiang Starry Pharmaceutical Company Information
  9. 7.2.2 Zhejiang Starry Pharmaceutical Business Overview
  10. 7.2.3 Zhejiang Starry Pharmaceutical Ioversol Injection Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Zhejiang Starry Pharmaceutical Ioversol Injection Product Portfolio
  12. 7.2.5 Zhejiang Starry Pharmaceutical Recent Developments
  13. 7.3 Hengrui Pharmaceuticals
  14. 7.3.1 Hengrui Pharmaceuticals Company Information
  15. 7.3.2 Hengrui Pharmaceuticals Business Overview
  16. 7.3.3 Hengrui Pharmaceuticals Ioversol Injection Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Hengrui Pharmaceuticals Ioversol Injection Product Portfolio
  18. 7.3.5 Hengrui Pharmaceuticals Recent Developments
  19. 7.4 Bayer HealthCare Pharmaceuticals
  20. 7.4.1 Bayer HealthCare Pharmaceuticals Company Information
  21. 7.4.2 Bayer HealthCare Pharmaceuticals Business Overview
  22. 7.4.3 Bayer HealthCare Pharmaceuticals Ioversol Injection Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bayer HealthCare Pharmaceuticals Ioversol Injection Product Portfolio
  24. 7.4.5 Bayer HealthCare Pharmaceuticals Recent Developments
  25. 7.5 Neptunus Bio-pharmaceutical
  26. 7.5.1 Neptunus Bio-pharmaceutical Company Information
  27. 7.5.2 Neptunus Bio-pharmaceutical Business Overview
  28. 7.5.3 Neptunus Bio-pharmaceutical Ioversol Injection Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Neptunus Bio-pharmaceutical Ioversol Injection Product Portfolio
  30. 7.5.5 Neptunus Bio-pharmaceutical Recent Developments
  31. 7.6 Liebel-Flarsheim Company LLC
  32. 7.6.1 Liebel-Flarsheim Company LLC Company Information
  33. 7.6.2 Liebel-Flarsheim Company LLC Business Overview
  34. 7.6.3 Liebel-Flarsheim Company LLC Ioversol Injection Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Liebel-Flarsheim Company LLC Ioversol Injection Product Portfolio
  36. 7.6.5 Liebel-Flarsheim Company LLC Recent Developments
  37. 7.7 Bracco Imaging S.p.A.
  38. 7.7.1 Bracco Imaging S.p.A. Company Information
  39. 7.7.2 Bracco Imaging S.p.A. Business Overview
  40. 7.7.3 Bracco Imaging S.p.A. Ioversol Injection Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bracco Imaging S.p.A. Ioversol Injection Product Portfolio
  42. 7.7.5 Bracco Imaging S.p.A. Recent Developments
8 North America
  1. 8.1 North America Ioversol Injection Revenue (2021-2032)
  2. 8.2 North America Ioversol Injection Revenue by Type (2021-2032)
  3. 8.2.1 North America Ioversol Injection Revenue by Type (2021-2026)
  4. 8.2.2 North America Ioversol Injection Revenue by Type (2027-2032)
  5. 8.3 North America Ioversol Injection Revenue Share by Type (2021-2032)
  6. 8.4 North America Ioversol Injection Revenue by Application (2021-2032)
  7. 8.4.1 North America Ioversol Injection Revenue by Application (2021-2026)
  8. 8.4.2 North America Ioversol Injection Revenue by Application (2027-2032)
  9. 8.5 North America Ioversol Injection Revenue Share by Application (2021-2032)
  10. 8.6 North America Ioversol Injection Revenue by Country
  11. 8.6.1 North America Ioversol Injection Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Ioversol Injection Revenue by Country (2021-2026)
  13. 8.6.3 North America Ioversol Injection Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Ioversol Injection Revenue (2021-2032)
  2. 9.2 Europe Ioversol Injection Revenue by Type (2021-2032)
  3. 9.2.1 Europe Ioversol Injection Revenue by Type (2021-2026)
  4. 9.2.2 Europe Ioversol Injection Revenue by Type (2027-2032)
  5. 9.3 Europe Ioversol Injection Revenue Share by Type (2021-2032)
  6. 9.4 Europe Ioversol Injection Revenue by Application (2021-2032)
  7. 9.4.1 Europe Ioversol Injection Revenue by Application (2021-2026)
  8. 9.4.2 Europe Ioversol Injection Revenue by Application (2027-2032)
  9. 9.5 Europe Ioversol Injection Revenue Share by Application (2021-2032)
  10. 9.6 Europe Ioversol Injection Revenue by Country
  11. 9.6.1 Europe Ioversol Injection Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Ioversol Injection Revenue by Country (2021-2026)
  13. 9.6.3 Europe Ioversol Injection Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Ioversol Injection Revenue (2021-2032)
  2. 10.2 China Ioversol Injection Revenue by Type (2021-2032)
  3. 10.2.1 China Ioversol Injection Revenue by Type (2021-2026)
  4. 10.2.2 China Ioversol Injection Revenue by Type (2027-2032)
  5. 10.3 China Ioversol Injection Revenue Share by Type (2021-2032)
  6. 10.4 China Ioversol Injection Revenue by Application (2021-2032)
  7. 10.4.1 China Ioversol Injection Revenue by Application (2021-2026)
  8. 10.4.2 China Ioversol Injection Revenue by Application (2027-2032)
  9. 10.5 China Ioversol Injection Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ioversol Injection Revenue (2021-2032)
  2. 11.2 Asia Ioversol Injection Revenue by Type (2021-2032)
  3. 11.2.1 Asia Ioversol Injection Revenue by Type (2021-2026)
  4. 11.2.2 Asia Ioversol Injection Revenue by Type (2027-2032)
  5. 11.3 Asia Ioversol Injection Revenue Share by Type (2021-2032)
  6. 11.4 Asia Ioversol Injection Revenue by Application (2021-2032)
  7. 11.4.1 Asia Ioversol Injection Revenue by Application (2021-2026)
  8. 11.4.2 Asia Ioversol Injection Revenue by Application (2027-2032)
  9. 11.5 Asia Ioversol Injection Revenue Share by Application (2021-2032)
  10. 11.6 Asia Ioversol Injection Revenue by Country
  11. 11.6.1 Asia Ioversol Injection Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Ioversol Injection Revenue by Country (2021-2026)
  13. 11.6.3 Asia Ioversol Injection Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ioversol Injection Revenue (2021-2032)
  2. 12.2 SAMEA Ioversol Injection Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Ioversol Injection Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Ioversol Injection Revenue by Type (2027-2032)
  5. 12.3 SAMEA Ioversol Injection Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Ioversol Injection Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Ioversol Injection Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Ioversol Injection Revenue by Application (2027-2032)
  9. 12.5 SAMEA Ioversol Injection Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Ioversol Injection Revenue by Country
  11. 12.6.1 SAMEA Ioversol Injection Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Ioversol Injection Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Ioversol Injection Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst